veliparib
Showing 26 - 50 of 62
Recurrent Small Cell Lung Carcinoma Trial in United States (Laboratory Biomarker Analysis, Placebo, Temozolomide)
Completed
- Recurrent Small Cell Lung Carcinoma
- Laboratory Biomarker Analysis
- +3 more
-
Tampa, Florida
- +9 more
Oct 28, 2019
Non-squamous NSCLC Trial in Worldwide (Paclitaxel, Carboplatin, Cisplatin)
Completed
- Non-squamous Non-small Cell Lung Cancer
- Paclitaxel
- +4 more
-
Huntsville, Alabama
- +139 more
Feb 8, 2021
Small Cell Lung Cancer Trial in Worldwide (Veliparib, Carboplatin, Etoposide)
Completed
- Small Cell Lung Cancer
- Veliparib
- +3 more
-
Scottsdale, Arizona
- +61 more
May 4, 2020
Triple Negative Breast Cancer Trial in Worldwide (Cyclophosphamide, Placebo, Doxorubicin)
Completed
- Triple Negative Breast Cancer
- Cyclophosphamide
- +5 more
-
Scottsdale, Arizona
- +157 more
Jan 15, 2021
Squamous NSCLC Trial in Worldwide (Carboplatin, Veliparib, Paclitaxel)
Completed
- Squamous Non-Small Cell Lung Cancer
- Carboplatin
- +3 more
-
Jonesboro, Arkansas
- +224 more
Nov 13, 2020
Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United
Completed
- Ovarian Clear Cell Cystadenocarcinoma
- +7 more
- Bevacizumab
- +4 more
-
Aurora, Colorado
- +12 more
Jul 19, 2019
Anaplastic Astrocytoma, Brain Stem Glioma, Childhood Mixed Glioma Trial in United States (radiation, other, drug)
Completed
- Anaplastic Astrocytoma
- +12 more
- 3-Dimensional Conformal Radiation Therapy
- +5 more
-
Los Angeles, California
- +11 more
Jul 17, 2019
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified Trial in
Completed
- Cervical Adenocarcinoma
- +4 more
- Cisplatin
- +3 more
-
Los Angeles, California
- +24 more
Jul 17, 2019
Untreated Metastatic Colorectal Cancer Trial (Veliparib, Placebo, Modified FOLFIRI)
Completed
- Untreated Metastatic Colorectal Cancer
- Veliparib
- +5 more
- (no location specified)
Nov 16, 2018
Brain Metastases From NSCLC Trial (Veliparib, Placebo, Whole brain radiation therapy)
Completed
- Brain Metastases From Non-small Cell Lung Cancer
- Veliparib
- +2 more
- (no location specified)
May 2, 2018
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma Trial in United States (biological,
Completed
- Cervical Adenocarcinoma
- +7 more
- Filgrastim
- +4 more
-
Orange, California
- +77 more
Aug 6, 2019
Basal-Like Breast Carcinoma, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier Trial in United States (Laboratory Biomarker
Completed
- Basal-Like Breast Carcinoma
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +6 more
Jun 28, 2018
Solid Tumors Trial (veliparib)
Completed
- Solid Tumors
- veliparib
- (no location specified)
Nov 17, 2017
Breast Cancer Trial in United States (Veliparib, Standard radiation treatment)
Completed
- Breast Cancer
- Veliparib
- Standard radiation treatment
-
Boston, Massachusetts
- +4 more
Dec 13, 2017
Oncology, BRCA Mutated, High Grade Serous Ovarian Cancer Trial (Veliparib)
Completed
- Oncology
- +3 more
- Veliparib
- (no location specified)
Nov 17, 2017
Ovarian Cancer Trial in Kurume-shi,Fukuoka, Morioka-shi, Nagaizumi-cho (veliparib, carboplatin, paclitaxel)
Completed
- Ovarian Cancer
- veliparib
- +2 more
-
Kurume-shi,Fukuoka, Japan
- +2 more
Nov 16, 2017
Extensive Stage Small Cell Lung Carcinoma, Large Cell Lung Carcinoma, Neuroendocrine Carcinoma Trial in United States
Completed
- Extensive Stage Small Cell Lung Carcinoma
- +4 more
- Cisplatin
- +3 more
-
Loma Linda, California
- +427 more
Jan 17, 2019
Locally Advanced Rectal Cancer Trial in Australia, United States (veliparib, capecitabine, radiation)
Completed
- Locally Advanced Rectal Cancer
- veliparib
- +2 more
-
Scottsdale, Arizona
- +5 more
Nov 16, 2017
Adult Solid Tumor, Peritoneal Carcinomatosis, Recurrent Fallopian Tube Carcinoma Trial in Baltimore, Toronto (other, radiation,
Completed
- Adult Solid Neoplasm
- +4 more
- Laboratory Biomarker Analysis
- +3 more
-
Baltimore, Maryland
- +2 more
Nov 20, 2017
Estrogen Receptor Negative, HER2/Neu Negative, Male Breast Carcinoma Trial in Bronx, New York (Laboratory Biomarker Analysis,
Completed
- Estrogen Receptor Negative
- +9 more
- Laboratory Biomarker Analysis
- +3 more
-
Bronx, New York
- +5 more
Dec 21, 2017
Brain and CNS Tumors Trial in United States (drug, genetic, other, procedure, radiation)
Completed
- Brain and Central Nervous System Tumors
- temozolomide
- +13 more
-
Birmingham, Alabama
- +10 more
Jun 25, 2018
Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,
Withdrawn
- Functional Pancreatic Neuroendocrine Tumor
- +28 more
- Capecitabine
- +4 more
- (no location specified)
Sep 26, 2017
Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Hereditary Breast/Ovarian Cancer - BRCA1 Trial in Seattle
Completed
- Estrogen Receptor-negative Breast Cancer
- +8 more
- veliparib
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Aug 8, 2017